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Abstract:  
A simple and high-yielding procedure has been developed to synthesize disubstituted imidalozes 
using phenyl glyoxal monohydrate, ammonium acetate and aldehydes.  This synthetic protocol 
allows the preparation of a variety of 2,4 (s)-disubstituted imidalozes without using any catalyst, 
expensive or sensitive reagents.  A corresponding 2-aroyl-4(s) disubstituted imidalozes derivative 
has also been isolated as byproduct.  The effects of solvents have also been studied.  
 
Introduction: 
Imidazoles are present in many medicinally active organic compounds and natural products. For 
example, amino acid histidine, the hypnotic agent etomidate, the antiulcerative agent cimetidine, 
the proton pump inhibitor omeprazole, the fungicide ketoconazole and the benzodiazepine 
antagonist flumazenil are imidazoles. For this reason, there is a need for the developing concise 
and rapid method for the preparation of these types of compounds.
1-4
 
 
Results: 
Although chemistry, biology and pharmacology of imidazoles are very rich, synthetic studies of 
these agents without any catalyst at room temperature has not been investigated. Using our 
methods diverse imiadazoles was prepared at room temperature without acids or acidic catalysts 
(Scheme 1). 
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We describe herein a diverse, convergent, high yielding, environmentally friendly synthesis of 
functionalized imiadazoles at C-2 and C-4. Our method can be performed without using any 
acidic reagents or catalysts. This study reveals that the yield of the desired compound (2) is 
excellent when benzene, tetrahydrofuran and dichloromethane were used as solvent. The product 
ratio shifts extensively towards (2) when water was used as solvent but the overall yield becomes 
low (18%).  
 
The mechanism of the reaction is not clear. However, a more probable route can be advanced. In 
the presence of methanol, we postulate that this equilibrium would be shifted toward the 
hemiacetal form (Scheme 2).  
 
Scheme 2: 
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reactive species in polar solvents, for example in dichloromethane and dimethylformamide. This 
supports the auto-condensation and the formation of the benzoylphenylimidazole as the major 
cproduct. In contrast, the NMR spectrum recorded in CDCl3 in presence of methanol showed a  
peak near the methanolic methyl chemical shift (3.51ppm) and the presence of the aldehyde peak 
could not be detected. This confirms the existence of the hemiacetal form and therefore, 
formation of the 2, 4-(5)-diphenylimidazole. This condition should favor the incorporation of 
benzaldehyde at the C2 position of the imidazole ring. The data further suggests that, in other 
solvents, there is a competition between the aldehyde and the glyoxal for the C2 position of the 
heterocyclic ring. The compounds synthesized were obtained in good yields with a simple 
workup and without chromatographic purification in most of the cases. Various aldehydes have 
been used in this study with considerable successes (Scheme 3). 
Scheme 3: 
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Conclusion: 
In conclusion, we have developed a simple and effective procedure for the synthesis of 
disubstituted imidazoles at room temperature without using any catalyst acidic mediums.   
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